217 related articles for article (PubMed ID: 23395317)
1. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Burke C; Alexander Grant L; Goh V; Griffin N
Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
[TBL] [Abstract][Full Text] [Related]
2. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Seale MK; Catalano OA; Saini S; Hahn PF; Sahani DV
Radiographics; 2009 Oct; 29(6):1725-48. PubMed ID: 19959518
[TBL] [Abstract][Full Text] [Related]
3. New contrast agents for imaging the liver.
Helmberger T; Semelka RC
Magn Reson Imaging Clin N Am; 2001 Nov; 9(4):745-66, vi. PubMed ID: 11694436
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Vogl TJ; Hammerstingl R; Schnell B; Eibl-Eibesfeldt B; Peqios W; Lissner J
Bildgebung; 1992 Dec; 59(4):195-9. PubMed ID: 1292771
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
6. [Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Rummeny EJ; Peters PE
Radiologe; 1992 May; 32(5):225-31. PubMed ID: 1635982
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC
Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
[TBL] [Abstract][Full Text] [Related]
8. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
Fowler KJ; Brown JJ; Narra VR
Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
11. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Giovagnoni A; Paci E
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents.
Goodwin MD; Dobson JE; Sirlin CB; Lim BG; Stella DL
Radiographics; 2011 Oct; 31(6):1547-68. PubMed ID: 21997981
[TBL] [Abstract][Full Text] [Related]
13. Primovist, Eovist: what to expect?
Van Beers BE; Pastor CM; Hussain HK
J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332
[TBL] [Abstract][Full Text] [Related]
14. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
De Gaspari A; De Cobelli F; Del Maschio A
Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
[TBL] [Abstract][Full Text] [Related]
15. Biliary MR imaging with Gd-EOB-DTPA and its clinical applications.
Lee NK; Kim S; Lee JW; Lee SH; Kang DH; Kim GH; Seo HI
Radiographics; 2009 Oct; 29(6):1707-24. PubMed ID: 19959517
[TBL] [Abstract][Full Text] [Related]
16. Gadoxetic acid-enhanced hepatobiliary phase MR imaging: cellular insight.
Pastor CM
Radiology; 2010 Nov; 257(2):589. PubMed ID: 20959554
[No Abstract] [Full Text] [Related]
17. MRI findings of hepatocellular carcinoma.
Wiwanitkit V
Magn Reson Imaging; 2011 Feb; 29(2):303. PubMed ID: 21129874
[No Abstract] [Full Text] [Related]
18. MRI findings of rapidly progressive hepatocellular carcinoma.
Kierans AS; Leonardou P; Hayashi P; Brubaker LM; Elazzazi M; Shaikh F; Semelka RC
Magn Reson Imaging; 2010 Jul; 28(6):790-6. PubMed ID: 20427139
[TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Reimer P; Schneider G; Schima W
Eur Radiol; 2004 Apr; 14(4):559-78. PubMed ID: 14986050
[TBL] [Abstract][Full Text] [Related]
20. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]